ArticleFrontiers in endocrinology2025
Safety enhancement of improved hydrodissection for microwave ablation in lymph node metastasis from papillary thyroid carcinoma: a comparative study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Safety and Efficacy of Thermal Ablation for Cervical Lymph Node Metastasis from Papillary Thyroid Carcinoma: A Systematic Review of Available Evidence.Medical sciences (Basel, Switzerland) · 2026Pooled it
- Thermal field management in thyroid ablation for papillary thyroid carcinoma: Advancing precision and patient-centered care.World journal of radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to evaluate the efficacy and safety of an improved hydrodissection technique based on the perilymph-nodal space (PLNS) when applied during microwave ablation for treating lymph node metastases (LNM) arising from papillary thyroid carcinoma (PTC). Methods: A retrospective analysis was conducted on data from 266 patients (95 males, 171 females, mean age 41.3 ± 14.0 years, range 16-88) who underwent MWA for LNM. Of these, 142 patients received traditional hydrodissection (traditional group), while 124 underwent the improved technique. Safety outcomes were assessed by comparing complication rates between the two groups. Additionally, the characteristics of the hydrodissected fascial spaces, complications, and follow-up results were documented. Results: All patients underwent successful hydrodissection as planned. The improved hydrodissection group demonstrated a lower incidence of hoarseness compared to the traditional group (4.8% vs. 8.4%, p >0.05). Notably, in region VI cases, the improved technique significantly reduced the incidence of hoarseness (7.5% vs. 25%, p = 0.006). Additionally, the median recovery time for hoarseness was shorter in the improved group (3 vs. 6 months, p <0.05). During follow-up, neither group exhibited local recurrence. The tumor disappearance rates were comparable between the groups (75.4% vs. 65.3%, p >0.05). Conclusion: The PLNS-based improved hydrodissection technique demonstrated enhanced safety compared to traditional hydrodissection during MWA for LNM, especially for region VI lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.